Alpa Laboratories share news, announcements and annual reports
NSE: ALPABSE: 532878Pharmaceuticals & BiotechnologySmall Cap
Alpa Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2007
Last close ₹50.38down ₹2.24 (4.26%)BSE ₹49.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹52.62.
30 Oct: open ₹51.50, high ₹51.65, low ₹50.00
52-week range of traded prices to 30 Oct 2026
₹46.10Low, 30 Mar 2026₹93.85High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹106 Cr2,659th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.57
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 17,77166.0% delivered
Alpa Laboratories results
66 filed, newest first. Page 2 of 2.
Feb 2014
15 Feb · Results
Nov 2013
14 Nov · Results
Aug 2013
May 2013
31 May · Results
Feb 2013
Nov 2012
Aug 2012
May 2012
29 May · Results
Feb 2012
Nov 2011
Aug 2011
May 2011
30 May · Results
Apr 2011
29 Apr · Results
Company will not be declaring the unaudited results for the Quarter and Year ended March 31, 2011 as it will be declaring its audited financial result for the same shortly.
Feb 2011
Oct 2010
Apr 2009
22 Apr · Results
As the company will be declaring its Audited financial results shortly, it will not be declaring Unaudited results for the quarter and Year ended March 2009.